ZA892908B - Pertussis toxoid vaccine - Google Patents
Pertussis toxoid vaccineInfo
- Publication number
- ZA892908B ZA892908B ZA892908A ZA892908A ZA892908B ZA 892908 B ZA892908 B ZA 892908B ZA 892908 A ZA892908 A ZA 892908A ZA 892908 A ZA892908 A ZA 892908A ZA 892908 B ZA892908 B ZA 892908B
- Authority
- ZA
- South Africa
- Prior art keywords
- pertussis toxoid
- toxoid vaccine
- vaccine
- pertussis
- whooping cough
- Prior art date
Links
- 201000005702 Pertussis Diseases 0.000 title abstract 2
- 229940031572 toxoid vaccine Drugs 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US18388488A | 1988-04-20 | 1988-04-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA892908B true ZA892908B (en) | 1990-04-25 |
Family
ID=22674711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA892908A ZA892908B (en) | 1988-04-20 | 1989-04-20 | Pertussis toxoid vaccine |
Country Status (10)
Country | Link |
---|---|
US (1) | US5989564A (de) |
EP (1) | EP0338566B1 (de) |
JP (1) | JP2889923B2 (de) |
AT (1) | ATE110964T1 (de) |
AU (1) | AU631351B2 (de) |
DE (1) | DE68917972T2 (de) |
DK (1) | DK192489A (de) |
ES (1) | ES2059605T3 (de) |
YU (1) | YU47972B (de) |
ZA (1) | ZA892908B (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5453272A (en) * | 1992-10-02 | 1995-09-26 | Alberta Research Council | Lectin derived carbohydrate binding-peptide |
AU686116B2 (en) * | 1992-10-02 | 1998-02-05 | Alberta Research Council Inc. | Anti-inflammatory tolerogenic and immunoinhibiting properties of carbohydrate binding-peptides |
US5856122A (en) * | 1993-08-24 | 1999-01-05 | University Of Alberta | Modification of pertussis toxin |
WO2021001540A1 (en) | 2019-07-04 | 2021-01-07 | Proxi Biotech Aps | Detoxification of proteins |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8512972D0 (en) * | 1985-05-22 | 1985-06-26 | Univ Glasgow | Vaccine production |
US4762710A (en) * | 1986-06-16 | 1988-08-09 | The United States Of America As Represented By The Department Of Health And Human Services | Novel method of preparing toxoid by oxidation and metal ions |
-
1989
- 1989-04-19 AU AU33182/89A patent/AU631351B2/en not_active Ceased
- 1989-04-20 ZA ZA892908A patent/ZA892908B/xx unknown
- 1989-04-20 ES ES89107157T patent/ES2059605T3/es not_active Expired - Lifetime
- 1989-04-20 JP JP1101487A patent/JP2889923B2/ja not_active Expired - Fee Related
- 1989-04-20 DK DK192489A patent/DK192489A/da not_active Application Discontinuation
- 1989-04-20 AT AT89107157T patent/ATE110964T1/de not_active IP Right Cessation
- 1989-04-20 YU YU80389A patent/YU47972B/sh unknown
- 1989-04-20 DE DE68917972T patent/DE68917972T2/de not_active Expired - Fee Related
- 1989-04-20 EP EP89107157A patent/EP0338566B1/de not_active Expired - Lifetime
-
1991
- 1991-09-12 US US07/759,822 patent/US5989564A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP0338566B1 (de) | 1994-09-07 |
AU631351B2 (en) | 1992-11-26 |
JP2889923B2 (ja) | 1999-05-10 |
YU80389A (en) | 1992-05-28 |
EP0338566A3 (en) | 1990-08-22 |
YU47972B (sh) | 1996-08-13 |
US5989564A (en) | 1999-11-23 |
DE68917972D1 (de) | 1994-10-13 |
DE68917972T2 (de) | 1995-01-05 |
DK192489A (da) | 1989-10-21 |
JPH0272200A (ja) | 1990-03-12 |
EP0338566A2 (de) | 1989-10-25 |
ATE110964T1 (de) | 1994-09-15 |
AU3318289A (en) | 1989-10-26 |
DK192489D0 (da) | 1989-04-20 |
ES2059605T3 (es) | 1994-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5182109C1 (en) | Vaccine preparation comprising a bacterial toxin adjuvant | |
PL393584A1 (pl) | Szczepionka | |
GR3022174T3 (en) | Hepatitis vaccines containing 3-o-deacylated monophoshoryl lipid a. | |
GR1002545B (el) | Μεθοδος παρασκευης νεων συνθεσεων ινσουλινης. | |
LU91595I2 (fr) | Combinaison d'anatoxine diphtérique, d'anatoxine tétanique, d'anatoxine coquelucheuse, d'hémagglutinine filamenteuse, de pertactine et de polyoside capsulaire d'haemophilus influenzae type b (InfanrixHib) | |
DK208985D0 (da) | Antigent praeparat og fremgangsmaade til isolering af et saadantpraeparat | |
DE69733285D1 (de) | Azellulärer Pertussis-Impfstoff, der ein Diphtheriae- und Tetanus-Toxoid enthält | |
EP0474646A4 (en) | Bordetella vaccines | |
EP0269729A4 (de) | Verfahren zur herstellung von toxoid. | |
MX9200793A (es) | Tetrahidropirinas y metodo para su preparacion. | |
EP0338566A3 (en) | Pertussis toxoid vaccine | |
EP0463157A4 (en) | Lfa-3 as a vaccine adjuvant | |
CY1935A (en) | Novel vaccine and method therefor | |
EP0484403A4 (en) | Lipid a analog/immunogenic carrier conjugates and the use thereof as vaccines | |
ZA895573B (en) | Bordetella pertussis vaccine | |
GB8918206D0 (en) | Tuberculosis vaccine | |
CA2004206A1 (en) | Method for preparing pertussis toxin toxoid | |
NZ236230A (en) | Bordetella pertussis toxins genetically modified to remove toxicity but retain immunogenicity, vaccines | |
IL84276A0 (en) | Vaccine against whooping cough | |
EP0563288A4 (en) | Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines | |
IE892369L (en) | Bordetella pertussis vaccine | |
GR3022679T3 (en) | Vaccine adjuvant comprising a tetra-polyol | |
IE882702L (en) | Antimalaria vaccines |